Evidence map›Paper›PMID 29523100›Full record

ArticleBMC public health2018

Loss-to-follow-up and delay to treatment initiation in Pakistan's national tuberculosis control programme.

Syed Mustafa Ali, Farah Naureen, Arif Noor, Irum Fatima, Kerri Viney, Muhammad Ishaq, Naveed Anjum, Aamna Rashid, Ghulam Rasool Haider, Muhammad Aamir Khan and 1 more

Abstract read
In one paragraph

Article in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Losses along the tuberculosis sputum sample referral cascade for Mpongwe District, Zambia.African journal of primary health care & family medicine · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Syed Mustafa AliMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan. symustafa@mercycorps.org.ORCID 0000-0001-9393-9049
Farah NaureenMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Arif NoorMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Irum FatimaMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Kerri VineyAustralian National University, Canberra, Australia.
Muhammad IshaqMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Naveed AnjumMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Aamna RashidMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Ghulam Rasool HaiderMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Muhammad Aamir KhanMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.
Javariya AamirMercy Corps, Rawal Chowk, Murree Road, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearchers and policy-makers have identified loss to follow-up as a major programmatic problem. Therefore, the objective of this study is to quantify TB related pre-treatment loss to follow up and treatment delay in private sector health care facilities in Pakistan.

methodsThis was a retrospective, descriptive cohort study using routinely collected programmatic data from TB referral, diagnosis and treatment registers. Data from 48 private healthcare facilities were collected using an online questionnaire prepared in ODK Collect, for the period October 2015 to March 2016. Data were analysed using SPSS. We calculated the: (1) number and proportion of patients who were lost to follow-up during the diagnostic period, (2) number and proportion of patients with pre-treatment loss to follow-up, and (3) the number of days between diagnosis and initiation of treatment.

resultsOne thousand five hundred ninety-six persons with presumptive TB were referred to the laboratory. Of these, 96% (n = 1538) submitted an on-the-spot sputum sample. Of the 1538 people, 1462 (95%) people subsequently visited the laboratory to submit the early morning (i.e. the second) sample. Hence, loss to follow-up during the diagnostic process was 8% overall (n = 134). Of the 1462 people who submitted both sputum samples, 243 (17%) were diagnosed with sputum smear-positive pulmonary TB and 231 were registered for anti-TB treatment, hence, loss in the pre-treatment phase was 4.9% (n = 12). 152 persons with TB (66%) initiated TB treatment either on the day of TB diagnosis or the next day. A further 79 persons with TB (34%) commenced TB treatment within a mean time of 7 days (range 2 to 64 days).

conclusionConcentrated efforts should be made by the National TB Control Programme to retain TB patients and innovative methods such as text reminders and behavior change communication may need to be used and tested.

Indexed as

Lost to Follow-UpFemaleHumansMalePakistanRegistriesRetrospective StudiesSputumTime-to-TreatmentTuberculosis, PulmonaryLost to follow-up during diagnosisPakistan’s TB control programPre-treatment loss to follow upTreatment delayTuberculosis

Identifiers

PMID29523100
PMCPMC5845151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.